Synaptogenix, Inc. financial data

Symbol
SNPX on Nasdaq
Location
New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.2K % +308%
Debt-to-equity 52.7 % +31%
Return On Equity -240 % -469%
Return On Assets -149 % -408%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.13M shares +426%
Common Stock, Shares, Outstanding 4.53M shares +234%
Entity Public Float 6.62M USD 0%
Common Stock, Value, Issued 453 USD +231%
Weighted Average Number of Shares Outstanding, Basic 2.55M shares +111%
Weighted Average Number of Shares Outstanding, Diluted 2.55M shares +111%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 203K USD
Research and Development Expense 688K USD -60.7%
General and Administrative Expense 6.9M USD +37.7%
Operating Income (Loss) -1.8M USD +9.03%
Nonoperating Income (Expense) -19.1M USD -2192%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.6M USD -224%
Net Income (Loss) Attributable to Parent -26.6M USD -224%
Earnings Per Share, Basic 4 USD/shares +68.9%
Earnings Per Share, Diluted 4 USD/shares -82.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.4M USD -42.5%
Assets, Current 18.3M USD -17.6%
Property, Plant and Equipment, Net 10.1K USD -28.3%
Assets 18.4M USD -19.6%
Accounts Payable, Current 950K USD +232%
Accrued Liabilities, Current 92.4K USD +69.4%
Liabilities, Current 1.04M USD +206%
Liabilities 1.69M USD -82.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 5.7K USD 0%
Retained Earnings (Accumulated Deficit) -68.5M USD -64.9%
Stockholders' Equity Attributable to Parent 16.1M USD +25.5%
Liabilities and Equity 18.4M USD -19.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2M USD -9.23%
Net Cash Provided by (Used in) Financing Activities -822K USD
Net Cash Provided by (Used in) Investing Activities -500K USD -24434%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 4.53M shares +234%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.45M USD -92.6%
Deferred Tax Assets, Valuation Allowance 33M USD +9.19%
Payments to Acquire Property, Plant, and Equipment 2.04K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -27.1M USD -197%
Deferred Tax Assets, Operating Loss Carryforwards 35.2M USD +11.7%
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 84.5M USD +55.6%
Depreciation, Depletion and Amortization 1.03K USD -26.2%
Share-based Payment Arrangement, Expense 14.7K USD -96.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%